Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01733615 · ClinicalTrials.gov registry record
Discovering New Biomarkers For Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA
A clinical trial, sponsored by Emory University.
- Terminated
- Registry status
- 3
- Enrollment target
NCT01733615: Clinical Trial study, sponsored by Emory University.
NCT01733615 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01733615 was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to find out more about some of the unusual chemicals (called oligosaccharides) that can occur naturally as a result of processes in the body. Researchers want to look at how these chemicals change with time and how they change between different patients with MPSIVA. These unusual chemicals were recently discovered in the urine from patients with MPSIVA. The investigators would like to study these chemicals before a specific enzyme replacement therapy is used. If the investigators understand how these chemicals change, the investigators may be able to use them to monitor this condition in the near future as well as help doctors know whether certain therapies work well in their patients.
Primary Outcome
The variability of oligosaccharides in the same patient over different time points and urine specimen type will be evaluated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-02 |
Why NCT01733615 stopped before completion
NCT01733615 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01733615 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01733615 about?
NCT01733615 is a clinical study titled "Discovering New Biomarkers For Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA". The purpose of this study is to find out more about some of the unusual chemicals (called oligosaccharides) that can occur naturally as a result of processes in the body. Researchers want to look at how these chemicals change with time and how they change between different patients with MPSIVA. Thes...
What is the current status of trial NCT01733615?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2012-06. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT01733615?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia